Step 1 topics → Hematology and Oncology → Hodgkin Lymphoma

Hodgkin Lymphoma

USMLE Step 1 trap: Confuses lymphocyte-rich with nodular sclerosis as the most common Hodgkin subtype. Nodular sclerosis is the most common Hodgkin lymphoma subtype (~70%), typically affecting young women with mediastinal involvement.

Hodgkin lymphoma (HL) is a B-cell malignancy defined by the presence of Reed-Sternberg (RS) cells within a reactive inflammatory background, and it's a reliable source of USMLE Step 1 questions. The misconception the exam targets most is assigning CD45 to RS cells — they don't express it. RS cells are CD15+, CD30+, and CD45-negative, which is what makes them biologically unusual and immunophenotypically distinct from virtually every other lymphoid cell you'll encounter. What makes HL distinct from non-Hodgkin lymphoma isn't just histology but a completely different clinical behavior: bimodal age distribution, contiguous nodal spread, high curability, and a tight EBV association.

The exam tests HL at multiple levels. At the recall level, you need RS cell morphology (binucleated giant cells with prominent 'owl-eye' nucleoli) and immunophenotype cold. At the application level, you'll be handed a clinical vignette — young woman, mediastinal mass, fever and night sweats — and asked to identify subtype, marker, or spread pattern. At the interpretation level, a passage might describe a flow cytometry or biopsy result and ask you to reason through what the findings mean for diagnosis or prognosis. USMLE Step 1 frequently uses the immunophenotype as the trap.

The biggest traps students fall into: assuming RS cells express CD45 like normal lymphocytes (they don't — they're CD45-negative), confusing lymphocyte-rich with nodular sclerosis as the most common subtype, and mixing up the spread pattern of HL with NHL. These aren't random errors — they come from pattern-matching to general lymphoma rules without appreciating what makes HL unique. Lock down the exceptions and you'll own this topic.

From real student decks
86%have cards covering this topic
62%have mature cards
1.0median lapses in 14 days

Common misconceptions

Common mistake
Wrong: Lymphocyte-rich is the most common subtype of Hodgkin lymphoma.
Right: Nodular sclerosis is the most common Hodgkin lymphoma subtype (~70%), typically affecting young women with mediastinal involvement.
Lymphocyte-rich sounds like it should be common because lymphocytes are abundant in lymphoid tissue, but it's actually one of the less frequent subtypes. Nodular sclerosis accounts for roughly 70% of all Hodgkin lymphoma cases and is the classic presentation you'll see on USMLE Step 1 — young woman, anterior mediastinal mass, collagen bands on biopsy creating nodules. When a question says 'most common Hodgkin subtype,' the answer is nodular sclerosis, full stop.
Common mistake
Wrong: Reed-Sternberg cells are CD15-negative and CD45-positive like normal lymphocytes.
Right: Classic Reed-Sternberg cells are CD15+, CD30+, and CD45-NEGATIVE, distinguishing them from normal lymphocytes and most other lymphomas.
The instinct to assign CD45 to RS cells comes from overgeneralizing 'lymphoma = lymphocyte markers,' but RS cells are biologically weird — they're B-cell derived yet have lost most normal B-cell surface markers. The correct profile is CD15+, CD30+, and CD45-NEGATIVE. CD30 is especially useful clinically (targeted by brentuximab vedotin), and the absence of CD45 is what distinguishes RS cells from virtually every other lymphoid cell you'll encounter.
Common mistake
Wrong: Hodgkin lymphoma spreads hematogenously and non-contiguously like NHL.
Right: Hodgkin lymphoma spreads contiguously through adjacent lymph node groups, which is why radiation to involved fields is effective and staging is predictive.
Non-Hodgkin lymphomas frequently disseminate hematogenously, appearing in non-adjacent nodes or extranodal sites early — which is why NHL is often advanced at presentation. Hodgkin lymphoma is fundamentally different: it marches through adjacent lymph node groups in an orderly, contiguous fashion. This predictable spread is why Ann Arbor staging works so well for HL and why localized radiation to involved fields can be curative — something that would fail completely if the disease were spreading hematogenously.
Common mistake
Wrong: Lymphocyte-depleted Hodgkin lymphoma is the most common subtype.
Right: Lymphocyte-depleted is the rarest and worst-prognosis subtype of Hodgkin lymphoma, seen in older and HIV-positive patients.
Lymphocyte-depleted HL is both the rarest subtype (under 5% of cases) and carries the worst prognosis — the near-absence of reactive lymphocytes means there's minimal immune response keeping the tumor in check. It's seen in older patients and those with HIV/AIDS. Confusing it with 'most common' flips everything: nodular sclerosis is common and has good prognosis; lymphocyte-depleted is rare and has poor prognosis. The name is the clue — depleted lymphocytes = depleted immune surveillance = bad outcome.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Know the Reed-Sternberg cell inside out: its binucleated owl-eye morphology, and its CD15+/CD30+/CD45− immunophenotype that sets it apart from normal lymphocytes and most other lymphomas.
  2. Distinguish the four classic Hodgkin subtypes by demographic, frequency, and prognosis — especially nodular sclerosis (most common, young women, mediastinal), mixed cellularity (EBV-associated, older men), lymphocyte predominant (best prognosis), and lymphocyte depleted (rarest, worst prognosis, HIV/elderly).
  3. Recognize Hodgkin lymphoma's clinical signature: bimodal age distribution (teens/young adults and >55), painless cervical or mediastinal lymphadenopathy, B symptoms (fever, drenching night sweats, >10% weight loss), and contiguous nodal spread that contrasts with NHL's hematogenous, non-contiguous spread.

Can you avoid these mistakes?

A biopsy shows large binucleated cells with prominent eosinophilic nucleoli surrounded by a mixed inflammatory infiltrate. Flow cytometry reveals CD15+, CD30+, CD45− cells. What is the diagnosis, and which subtype is most likely if collagen bands are seen dividing the tissue into nodules?
A 24-year-old woman presents with a 3-month history of fatigue, 12-pound weight loss, and drenching night sweats. CT shows a large anterior mediastinal mass and enlarged bilateral cervical lymph nodes. Which Hodgkin subtype does this presentation best fit, and what does 'contiguous spread' mean for how her disease staged?
On USMLE Step 1, a question asks you to rank Hodgkin subtypes from best to worst prognosis. What is the order, and what patient populations are associated with the two extremes?
A classmate says Reed-Sternberg cells must be CD45-positive because Hodgkin lymphoma is a B-cell tumor and B-cells express CD45. How do you correct this reasoning, and what is the actual immunophenotype of classic RS cells?

Related topics

Leukemia vs Lymphoma Framework Hematopoiesis and Lineage Differentiation RBC Physiology and Lifespan WBC Differential and Function Platelet Physiology and Primary Hemostasis

See how your Anki deck covers this topic.

Upload your deck for a free audit →